Details for Patent: 9,956,184
✉ Email this page to a colleague
Which drugs does patent 9,956,184 protect, and when does it expire?
Patent 9,956,184 protects EPIDIOLEX and is included in one NDA.
This patent has forty-three patent family members in ten countries.
Summary for Patent: 9,956,184
| Title: | Use of cannabinoids in the treatment of epilepsy |
| Abstract: | The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of "treatment-resistant epilepsy" (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs). |
| Inventor(s): | Guy; Geoffrey (London, GB), Wright; Stephen (London, GB), Mead; Alice (Cambridge, GB), Devinsky; Orrin (New York, NY) |
| Assignee: | GW Pharma Limited (Cambridge, GB) |
| Application Number: | 15/449,124 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,956,184 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,956,184
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms Res | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | USE IN COMBINATION WITH CLOBAZAM FOR TREATMENT OF SEIZURES IN PATIENTS WITH LENNOX GASTAUT SYNDROME | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,956,184
International Family Members for US Patent 9,956,184
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015275886 | ⤷ Subscribe | |||
| Australia | 2015275887 | ⤷ Subscribe | |||
| Australia | 2020217417 | ⤷ Subscribe | |||
| Australia | 2020220135 | ⤷ Subscribe | |||
| Australia | 2022202119 | ⤷ Subscribe | |||
| Australia | 2022209295 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
